Incidental Thyroid Cancer in Toxic and Nontoxic Goiter: is TSH Associated with Malignany Rate? Results of A Meta-Analysis
Tài liệu tham khảo
Boelaert, 2006, Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration, J Clin Endocrinol Metab, 91, 4295, 10.1210/jc.2006-0527
Fiore, 2009, Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role, Endocr Relat Cancer, 16, 1251, 10.1677/ERC-09-0036
Gerschpacher, 2010, Thyrotropin serum concentrations in patients with papillary thyroid microcancers, Thyroid, 20, 389, 10.1089/thy.2009.0139
Studebaker, 1985, A “rationalized” arcsine transform, J Speech Hear Res, 28, 455, 10.1044/jshr.2803.455
Kontopantelis, 2012, Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A simulation study, Stat Methods Med Res, 21, 409, 10.1177/0962280210392008
Elisei, 2010, Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question, J Clin Endocrinol Metab, 95, 1516, 10.1210/jc.2009-1536
From, 2000, Review of thyroid cancer cases among patients with previous benign thyroid disorders, Thyroid, 10, 697, 10.1089/10507250050137789
Gulcelik, 2006, The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency, J Surg Oncol, 94, 35, 10.1002/jso.20508
Iribarren, 2001, Cohort study of thyroid cancer in a San Francisco Bay area population, Int J Cancer, 93, 745, 10.1002/ijc.1377
Memon, 2002, Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East, Int J Cancer, 97, 82, 10.1002/ijc.1573
Memon, 2002, Benign thyroid disease and dietary factors in thyroid cancer: a case-control study in Kuwait, Br J Cancer, 86, 1745, 10.1038/sj.bjc.6600303
Omür, 2008, Concomitant hyperthyroidism in patients with thyroid carcinoma and the effects of iodine supplementation in an iodine-deficient area, Clin Nucl Med, 33, 769, 10.1097/RLU.0b013e318187eeb2
Pazaitou-Panayiotou, 2008, Mortality from thyroid cancer in patients with hyperthyroidism: the Theagenion Cancer Hospital experience, Eur J Endocrinol, 159, 799, 10.1530/EJE-08-0468
Botrugno, 2011, Incidental carcinoma in multinodular goiter: risk factors, Am Surg, 77, 1553, 10.1177/000313481107701149
Bron, 2004, Total thyroidectomy for clinically benign disease of the thyroid gland, Br J Surg, 91, 569, 10.1002/bjs.4507
Friguglietti, 2003, Total thyroidectomy for benign thyroid disease, Laryngoscope, 113, 1820, 10.1097/00005537-200310000-00030
Mishra, 2001, Total thyroidectomy for benign thyroid disorders in an endemic region, World J Surg, 25, 307, 10.1007/s002680020100
Prades, 2002, Multinodular goiter: surgical management and histopathological findings, Eur Arch Otorhinolaryngol, 259, 217, 10.1007/s00405-002-0455-0
Bradly, 2009, Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases, Surgery, 146, 1099, 10.1016/j.surg.2009.09.025
Cerci, 2007, Thyroid cancer in toxic and non-toxic multinodular goiter, J Postgrad Med, 53, 157, 10.4103/0022-3859.33855
Harach, 2002, Pathology of the autonomously functioning (hot) thyroid nodule, Ann Diagn Pathol, 6, 10, 10.1053/adpa.2002.30605
Mori, 2003, Thyroid nodular lesion: analysis of cancer risk based on Kuma Hospital experience, Pathol Int, 53, 579, 10.1046/j.1440-1827.2003.01530.x
Sakorafas, 2007, Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably benign thyroid disease, J Postgrad Med, 53, 23, 10.4103/0022-3859.30323
Berker, 2011, Prevalence of incidental thyroid cancer and its ultrasonographic features in subcentimeter thyroid nodules of patients with hyperthyroidism, Endocrine, 39, 13, 10.1007/s12020-010-9405-6
Lin, 2003, Prevalence of thyroid cancer in hyperthyroidism treated by surgery, Kaohsiung J Med Sci, 19, 379, 10.1016/S1607-551X(09)70480-2
Pradeep, 2007, Safety and efficacy of surgical management of hyperthyroidism: 15-year experience from a tertiary care center in a developing country, World J Surg, 31, 306, 10.1007/s00268-006-0572-9
Sahin, 2005, Thyroid cancer in hyperthyroidism: incidence rates and value of ultrasound-guided fine-needle aspiration biopsy in this patient group, J Endocrinol Invest, 28, 815, 10.1007/BF03347572
Senyurek Giles, 2008, The risk factors for malignancy in surgically treated patients for Gravesĉ disease, toxic multinodular goiter, and toxic adenoma, Surgery, 144, 1028, 10.1016/j.surg.2008.08.022
Gurleyik, 2005, Clinical importance of solitary solid nodule of the thyroid in endemic goiter region, Indian J Med Sci, 59, 388, 10.4103/0019-5359.16816
Miccoli, 2006, Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease, ANZ J Surg, 76, 123, 10.1111/j.1445-2197.2006.03667.x
Phitayakorn, 2008, Incidental thyroid carcinoma in patients with Graves’ disease, Am J Surg, 195, 292, 10.1016/j.amjsurg.2007.12.006
Fiore, 2012, Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease, J Clin Endocrinol Metab, 97, 1134, 10.1210/jc.2011-2735
Fiore, 2010, L-thyroxine treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27,914 patients, Endocr Relat Cancer, 17, 231, 10.1677/ERC-09-0251
Belfiore, 1990, Increased aggressiveness of thyroid cancer in patients with Graves’ disease, J Clin Endocrinol Metab, 70, 830, 10.1210/jcem-70-4-830
Filetti, 1990, The role of thyroid-stimulating antibodies of Graves’ disease in differentiated thyroid cancer, N Engl J Med, 318, 753, 10.1056/NEJM198803243181206
Hamburger, 1980, Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules, J Clin Endocrinol Metab, 50, 1089, 10.1210/jcem-50-6-1089